1. Home
  2. MATX vs ABVX Comparison

MATX vs ABVX Comparison

Compare MATX & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matson Inc.

MATX

Matson Inc.

N/A

Current Price

$204.73

Market Cap

6.8B

ML Signal

N/A

Logo Abivax SA American

ABVX

Abivax SA American

N/A

Current Price

$82.31

Market Cap

7.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MATX
ABVX
Founded
1882
2013
Country
United States
France
Employees
N/A
N/A
Industry
Marine Transportation
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.7B
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
MATX
ABVX
Price
$204.73
$82.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
12
Target Price
★ $292.50
$163.58
AVG Volume (30 Days)
259.1K
★ 688.1K
Earning Date
11-04-2026
09-21-2026
Dividend Yield
★ 0.74%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 13.01
N/A
Revenue
★ $3,344,500,000.00
N/A
Revenue This Year
$15.82
N/A
Revenue Next Year
N/A
$1,695.54
P/E Ratio
$15.91
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$102.42
$69.81
52 Week High
$240.87
$148.83

Technical Indicators

Market Signals
Indicator
MATX
ABVX
Relative Strength Index (RSI) 34.91 40.38
Support Level $202.02 $74.79
Resistance Level $205.48 $94.67
Average True Range (ATR) 8.61 3.64
MACD -0.79 -0.11
Stochastic Oscillator 9.55 10.02

Price Performance

Historical Comparison
MATX
ABVX

About MATX Matson Inc.

Matson Inc is engaged in providing ocean transportation and logistics services. The company has two reportable business segments: Ocean Transportation and Logistics. The Ocean Transportation segment provides ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, California, Okinawa, and different islands in the South Pacific. The Logistics segment offers long-haul and regional highway trucking services, warehousing and distribution services, supply chain management, and freight forwarding services. The firm generates the majority of its revenue from the Ocean Transportation segment.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Share on Social Networks: